Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS-Reference-Cited by-同舟云学术

Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS

Published:2018-10-02 Issue:12 Volume:93 Page:1524-1531
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Fraccaroli Alessia¹^ORCID,Prevalsek Dusan¹,Fritsch Susanne¹,Haebe Sarah¹,Bücklein Veit¹,Schulz Christoph¹,Hubmann Max¹,Stemmler Hans-Joachim¹,Ledderose Georg¹,Hausmann Andreas¹,Schmid Christoph²,Tischer Johanna¹

Affiliation:

1. Department of Medicine III, Hematopoietic Stem Cell Transplantation; University Hospital of Munich-Grosshadern, Ludwig-Maximilians University; Munich Germany

2. Department of Hematology and Oncology; Hospital Augsburg, Ludwig-Maximilians University; Munich Germany

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25281/fullpdf

Reference50 articles.

1. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) leukemia cooperative groups;Zittoun;N Engl J Med,1995

2. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure;Duval;J Clin Oncol,2010

3. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel;Witte;Blood,2017

4. Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation;Koh;J Exp Clin Cancer Res,2011

5. Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy;Ravandi;Blood,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

2. Treosulfan-Versus Melphalan-Based Reduced Intensity Conditioning in HLA-Haploidentical Transplantation for Patients ≥ 50 Years with Advanced MDS/AML;Cancers;2024-08-16

3. Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia;British Journal of Haematology;2024-06-04

4. Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies;Cancers;2024-01-26

5. PTCY-Based Haploidentical Donor Transplantation versus HLA-Matched Related and Unrelated Donor Transplantations in Patients with Refractory or Relapsed Lymphoma—A Matched-Pair Analysis;Cancers;2023-10-31